342 related articles for article (PubMed ID: 24405164)
21. Probiotics in critically ill patients.
Madsen K
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S116-8. PubMed ID: 18806700
[TBL] [Abstract][Full Text] [Related]
22. Probiotics and the skin.
Caramia G; Atzei A; Fanos V
Clin Dermatol; 2008; 26(1):4-11. PubMed ID: 18280898
[TBL] [Abstract][Full Text] [Related]
23. Immunology and probiotic impact of the newborn and young children intestinal microflora.
Bezirtzoglou E; Stavropoulou E
Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial.
Manzano S; De Andrés J; Castro I; Rodríguez JM; Jiménez E; Espinosa-Martos I
Benef Microbes; 2017 Aug; 8(4):569-578. PubMed ID: 28555502
[TBL] [Abstract][Full Text] [Related]
25. Probiotics for prevention and treatment of diarrhea.
Guandalini S
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
[TBL] [Abstract][Full Text] [Related]
26. Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children.
Simakachorn N; Bibiloni R; Yimyaem P; Tongpenyai Y; Varavithaya W; Grathwohl D; Reuteler G; Maire JC; Blum S; Steenhout P; Benyacoub J; Schiffrin EJ
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):174-81. PubMed ID: 21788759
[TBL] [Abstract][Full Text] [Related]
27. A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probiotics.
Topcuoglu S; Gursoy T; Ovalı F; Serce O; Karatekin G
J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1491-4. PubMed ID: 25163639
[TBL] [Abstract][Full Text] [Related]
28. Impact of probiotic supplementation on mortality of induced 1,2-dimethylhydrazine carcinogenesis in a mouse model.
Liboredo JC; Anastácio LR; Mattos LV; Nicoli JR; Correia MI
Nutrition; 2010; 26(7-8):779-83. PubMed ID: 20579593
[TBL] [Abstract][Full Text] [Related]
29. The role of probiotic bacteria in managing periodontal disease: a systematic review.
Matsubara VH; Bandara HM; Ishikawa KH; Mayer MP; Samaranayake LP
Expert Rev Anti Infect Ther; 2016 Jul; 14(7):643-55. PubMed ID: 27224284
[TBL] [Abstract][Full Text] [Related]
30. Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations.
Cohen SA; Woodfield MC; Boyle N; Stednick Z; Boeckh M; Pergam SA
Transpl Infect Dis; 2016 Oct; 18(5):699-705. PubMed ID: 27501401
[TBL] [Abstract][Full Text] [Related]
31. Safety Evaluations of
Kim MJ; Ku S; Kim SY; Lee HH; Jin H; Kang S; Li R; Johnston TV; Park MS; Ji GE
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747442
[TBL] [Abstract][Full Text] [Related]
32. Dealing with the remaining controversies of probiotic safety.
van den Nieuwboer M; Claassen E
Benef Microbes; 2019 Jul; 10(6):605-616. PubMed ID: 31131618
[TBL] [Abstract][Full Text] [Related]
33. Safety of probiotics that contain lactobacilli or bifidobacteria.
Borriello SP; Hammes WP; Holzapfel W; Marteau P; Schrezenmeir J; Vaara M; Valtonen V
Clin Infect Dis; 2003 Mar; 36(6):775-80. PubMed ID: 12627362
[TBL] [Abstract][Full Text] [Related]
34. Microorganisms with claimed probiotic properties: an overview of recent literature.
Fijan S
Int J Environ Res Public Health; 2014 May; 11(5):4745-67. PubMed ID: 24859749
[TBL] [Abstract][Full Text] [Related]
35. Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series.
Costa RL; Moreira J; Lorenzo A; Lamas CC
BMC Complement Altern Med; 2018 Dec; 18(1):329. PubMed ID: 30541524
[TBL] [Abstract][Full Text] [Related]
36. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
[TBL] [Abstract][Full Text] [Related]
37. Routine Use of Probiotics in Preterm Infants: Longitudinal Impact on the Microbiome and Metabolome.
Abdulkadir B; Nelson A; Skeath T; Marrs EC; Perry JD; Cummings SP; Embleton ND; Berrington JE; Stewart CJ
Neonatology; 2016; 109(4):239-47. PubMed ID: 26859305
[TBL] [Abstract][Full Text] [Related]
38. Probiotics for children with diarrhea: an update.
Guandalini S
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S53-7. PubMed ID: 18520336
[TBL] [Abstract][Full Text] [Related]
39. Probiotics for prevention of necrotizing enterocolitis in preterm infants.
AlFaleh K; Anabrees J
Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307
[TBL] [Abstract][Full Text] [Related]
40. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp.
Dugoua JJ; Machado M; Zhu X; Chen X; Koren G; Einarson TR
J Obstet Gynaecol Can; 2009 Jun; 31(6):542-552. PubMed ID: 19646321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
